A detailed history of Schonfeld Strategic Advisors LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 181,593 shares of IRWD stock, worth $639,207. This represents 0.01% of its overall portfolio holdings.

Number of Shares
181,593
Previous 347,040 47.67%
Holding current value
$639,207
Previous $2.26 Million 67.02%
% of portfolio
0.01%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.93 - $7.04 $650,206 - $1.16 Million
-165,447 Reduced 47.67%
181,593 $746,000
Q2 2024

Aug 14, 2024

SELL
$5.58 - $8.61 $5.39 Million - $8.31 Million
-965,204 Reduced 73.55%
347,040 $2.26 Million
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $10.3 Million - $19.1 Million
1,239,268 Added 1698.19%
1,312,244 $11.4 Million
Q4 2023

Feb 14, 2024

BUY
$8.79 - $11.51 $356,663 - $467,029
40,576 Added 125.23%
72,976 $834,000
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $1.56 Million - $2.14 Million
-188,878 Reduced 85.36%
32,400 $312,000
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $2.23 Million - $2.57 Million
221,278 New
221,278 $2.35 Million
Q4 2022

Feb 14, 2023

SELL
$9.9 - $12.43 $1.21 Million - $1.51 Million
-121,863 Reduced 83.15%
24,700 $306,000
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $1.49 Million - $1.81 Million
146,563 New
146,563 $1.52 Million
Q1 2022

May 16, 2022

SELL
$10.61 - $12.88 $426,522 - $517,776
-40,200 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $34,752 - $44,640
3,200 Added 8.65%
40,200 $469,000
Q3 2021

Nov 16, 2021

SELL
$11.92 - $13.92 $120,606 - $140,842
-10,118 Reduced 21.47%
37,000 $484,000
Q2 2021

Aug 16, 2021

BUY
$10.16 - $13.11 $478,718 - $617,716
47,118 New
47,118 $607,000
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $198,127 - $259,473
-21,677 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$8.58 - $14.01 $60,523 - $98,826
7,054 Added 48.24%
21,677 $219,000
Q4 2019

Feb 14, 2020

BUY
$8.22 - $14.0 $30,603 - $52,122
3,723 Added 34.16%
14,623 $195,000
Q3 2019

Nov 14, 2019

BUY
$8.59 - $10.96 $93,631 - $119,464
10,900 New
10,900 $94,000
Q2 2018

Aug 14, 2018

SELL
$11.83 - $16.2 $901,386 - $1.23 Million
-76,195 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$11.13 - $13.63 $848,050 - $1.04 Million
76,195 New
76,195 $1.18 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $539M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.